Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Primary systemic light chain amyloidosis (AL) and multiple myeloma (MM) are plasma cell dyscrasias.
• Distinguishing between AL and MM is crucial for appropriate treatment and prognosis.
• Immunophenotypic analysis aids in characterizing malignant plasma cells.

Purpose of the Study:

• To compare the immunophenotypic characteristics of malignant plasma cells in AL patients versus MM patients using flow cytometry.
• To identify potential differences that could explain variations in disease behavior.

Main Methods:

• Retrospective review of flow cytometry data from 51 AL patients and 150 MM patients.
• Analysis of plasma cell proportion, presence of distinct cell populations, and expression of CD19, CD138, and CD56.
• Assessment of light chain restriction in malignant plasma cells.

Main Results:

• AL patients had significantly lower bone marrow plasma cell proportions compared to MM patients.
• A higher frequency of dual plasma cell populations (normal and malignant) was observed in AL.
• Malignant plasma cells in AL showed increased CD19 and decreased CD138 and CD56 expression compared to MM.
• All AL patients exhibited light chain restriction, with a 72.5% proportion of lambda restriction.

Conclusions:

• Significant immunophenotypic differences exist between malignant plasma cells in AL and MM.
• These differences, including cell number, composition, and antigen expression, suggest a less malignant phenotype in AL clonal plasma cells compared to MM.